BayWa's Financial Restructuring Faces Mounting Pressure

BayWa launches T&G Global sale via Goldman Sachs, but €300M won't fix its €4B funding shortfall. The firm faces a legal probe over its 2023 accounts and a collapsed energy unit sale.

The German conglomerate BayWa is taking concrete steps to address its significant financial challenges, with the sale process for its T&G Global subsidiary now formally underway. Investment bank Goldman Sachs has been appointed to manage the divestment, and several potential buyers have expressed interest. While this demonstrates the company's ability to act, analysts point out that the anticipated proceeds of approximately €300 million will barely make a dent in a funding gap that now measures in the billions.

Legal and Regulatory Headwinds Compound Financial Strain

Beyond its balance sheet issues, BayWa is confronting serious legal and regulatory scrutiny. Munich's public prosecutor's office has initiated an investigation for breach of trust against former CEOs Klaus Josef Lutz and Marcus Pöllinger. The allegation centers on the systematic misrepresentation of the company's financial position in the 2023 annual report. Private premises have already been searched in connection with the probe. The accused individuals are presumed innocent.

Germany's financial regulator, BaFin, has formally criticized the 2023 financial statements. This official reprimand is expected to pave the way for damage claims from shareholders. In the aftermath, the incumbent auditor PwC has lost its mandate, and the professional oversight body Apas has opened a disciplinary procedure.

The Core Problem: A €4 Billion Funding Shortfall

The central issue remains a severe liquidity crunch. BayWa requires €4 billion by 2028, but only €1.3 billion of this sum is currently secured. A cornerstone of the original recovery plan—the sale of a 51% stake in its renewable energy unit, BayWa r.e., for up to €1.7 billion—collapsed in early 2025. When U.S. subsidies for renewable energy were cut, achievable sale prices plummeted, undermining the entire financial calculation.

Operational austerity measures are in full swing. The company plans to cut 1,300 jobs by 2027 and will permanently close 26 branch offices. Its financial forecast for 2026 has been withdrawn entirely, and the adjusted EBITDA target for 2027 has been lowered to about €140 million.

A glimmer of liquidity is expected from the already-completed sale of Cefetra. A payment of €45 million is due by April 30, 2026, supplemented by roughly €62 million from the repayment of shareholder loans. The deconsolidation of Cefetra is projected to reduce the group's bank debt by more than €600 million.

T&G Global: A Healthy Business with a Complex Exit

The asset on the block, T&G Global, is not a distressed unit but a profitable operation. The New Zealand-based subsidiary, which markets apple brands like Envy and Jazz in over 60 countries, reported 2024 revenue of US$1.3 billion and recently returned to profitability with a net income of US$16 million. BayWa, which holds just under 74% of the shares, intends to divest its entire stake.

The sale process, however, is not straightforward. A complication arises from minority shareholder Joy Wing Mau Group from Hong Kong, which holds a stake of nearly 20%. Potential buyers reportedly include agricultural-focused private equity firms such as Roc Partners, Paine Schwartz, and Hancock. A final decision has not yet been reached.

The Path Forward Hinges on Creditor Banks

The critical factor for BayWa's timeline is the stance of its creditor banks. If they agree to extend the current standstill agreement until autumn 2026, management will gain the necessary breathing room to execute its revised restructuring plan. Consequently, the audited group financial statements for 2025 are now expected to be delayed until the fourth quarter of 2026. Until then, a reliable fundamental assessment of the company's situation will be virtually impossible.